Global Markets Direct Reports

Endocrine Gland Disorders (Hormonal Disorders) - Drugs in Development, 2021

Endocrine Gland Disorders (Hormonal Disorders) - Drugs in Development, 2021 Summary Endocrine Gland Disorders (Hormonal Disorders) - Drugs in Develo...

Published: Apr-2021 | No. of Pages: 50
$ 2000
Liposarcoma (Oncology) - Drugs in Development, 2021

Liposarcoma (Oncology) - Drugs in Development, 2021 Summary Liposarcoma (Oncology) - Drugs in Development, 2021 provides an overview of the Liposarc...

Published: Apr-2021 | No. of Pages: 80
$ 2000
Paralysis (Central Nervous System) - Drugs in Development, 2021

Paralysis (Central Nervous System) - Drugs in Development, 2021 Summary Paralysis (Central Nervous System) - Drugs in Development, 2021 provides an ...

Published: Apr-2021 | No. of Pages: 30
$ 2000
Burkitt Lymphoma (Oncology) - Drugs in Development, 2021

Burkitt Lymphoma (Oncology) - Drugs in Development, 2021 Summary Burkitt Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of th...

Published: Apr-2021 | No. of Pages: 110
$ 2000
Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase 2 (Calcium Pump 2 or Calcium Transporting ATPase Sarcoplasmic Reticulum Type Slow Twitch Skeletal Muscle Isoform or Endoplasmic Reticulum Class 1/2 Ca(2+) ATPase or SERCA2 or ATP2A2 or EC 7.2.2.10) - Drugs in Development, 2021

Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase 2 (Calcium Pump 2 or Calcium Transporting ATPase Sarcoplasmic Reticulum Type Slow Twitch Skeletal Mu...

Published: Apr-2021 | No. of Pages: 35
$ 3000
Complement C1s Subcomponent (C1 Esterase or Complement Component 1 Subcomponent S or C1S or EC 3.4.21.42) - Drugs in Development, 2021

Complement C1s Subcomponent (C1 Esterase or Complement Component 1 Subcomponent S or C1S or EC 3.4.21.42) - Drugs in Development, 2021 Summary Compl...

Published: Apr-2021 | No. of Pages: 40
$ 3000
Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 1 (Membrane Component Chromosome 6 Surface Marker 1 or Phosphodiesterase I/Nucleotide Pyrophosphatase 1 or Plasma Cell Membrane Glycoprotein PC1 or ENPP1 or EC 3.1.4.1 or EC 3.6.1.9) - Drugs in Development, 2021

Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 1 (Membrane Component Chromosome 6 Surface Marker 1 or Phosphodiesterase I/Nucleotide P...

Published: Apr-2021 | No. of Pages: 30
$ 3000
Norovirus Infections (Infectious Disease) - Drugs in Development, 2021

Norovirus Infections (Infectious Disease) - Drugs in Development, 2021 Summary Norovirus Infections (Infectious Disease) - Drugs in Development, 202...

Published: Apr-2021 | No. of Pages: 50
$ 2000
Simplexvirus (HSV) Infections (Infectious Disease) - Drugs in Development, 2021

Simplexvirus (HSV) Infections (Infectious Disease) - Drugs in Development, 2021 Summary Simplexvirus (HSV) Infections (Infectious Disease) - Drugs i...

Published: Apr-2021 | No. of Pages: 70
$ 2000
Partial Seizure (Central Nervous System) - Drugs in Development, 2021

Partial Seizure (Central Nervous System) - Drugs in Development, 2021 Summary Partial Seizure (Central Nervous System) - Drugs in Development, 2021 ...

Published: Apr-2021 | No. of Pages: 40
$ 2000
Cachexia (Musculoskeletal) - Drugs in Development, 2021

Cachexia (Musculoskeletal) - Drugs in Development, 2021 Summary Cachexia (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the ...

Published: Apr-2021 | No. of Pages: 50
$ 2000
Sclerostin (SOST) - Drugs in Development, 2021

Sclerostin (SOST) - Drugs in Development, 2021 Summary Sclerostin (SOST) - Drugs in Development, 2021 provides in depth analysis on Sclerostin (SOST...

Published: Apr-2021 | No. of Pages: 35
$ 3000
CREB Binding Protein (CREBBP or EC 2.3.1.48) - Drugs in Development, 2021

CREB Binding Protein (CREBBP or EC 2.3.1.48) - Drugs in Development, 2021 Summary CREB Binding Protein (CREBBP or EC 2.3.1.48) - Drugs in Developmen...

Published: Apr-2021 | No. of Pages: 40
$ 3000
Egl Nine Homolog 1 (Hypoxia Inducible Factor Prolyl Hydroxylase 2 or Prolyl Hydroxylase Domain Containing Protein 2 or SM 20 or EGLN1 or EC 1.14.11.29) - Drugs in Development, 2021

Egl Nine Homolog 1 (Hypoxia Inducible Factor Prolyl Hydroxylase 2 or Prolyl Hydroxylase Domain Containing Protein 2 or SM 20 or EGLN1 or EC 1.14.11.29...

Published: Apr-2021 | No. of Pages: 30
$ 3000
Diabetic Complications (Metabolic Disorders) - Drugs in Development, 2021

Diabetic Complications (Metabolic Disorders) - Drugs in Development, 2021 Summary Diabetic Complications (Metabolic Disorders) - Drugs in Developmen...

Published: Apr-2021 | No. of Pages: 50
$ 2000
Streptococcal Infections (Infectious Disease) - Drugs in Development, 2021

Streptococcal Infections (Infectious Disease) - Drugs in Development, 2021 Summary Streptococcal Infections (Infectious Disease) - Drugs in Developm...

Published: Apr-2021 | No. of Pages: 45
$ 2000
Pemphigus (Immunology) - Drugs in Development, 2021

Pemphigus (Immunology) - Drugs in Development, 2021 Summary Pemphigus (Immunology) - Drugs in Development, 2021 provides an overview of the Pemphigu...

Published: Apr-2021 | No. of Pages: 30
$ 2000
Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021

Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021 Summary Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021 provides an overvi...

Published: Apr-2021 | No. of Pages: 55
$ 2000
Solute Carrier Family 2 Facilitated Glucose Transporter Member 1 (Glucose Transporter Type 1 Erythrocyte/Brain or GLUT1 or HepG2 Glucose Transporter or SLC2A1) - Drugs in Development, 2021

Solute Carrier Family 2 Facilitated Glucose Transporter Member 1 (Glucose Transporter Type 1 Erythrocyte/Brain or GLUT1 or HepG2 Glucose Transporter o...

Published: Apr-2021 | No. of Pages: 35
$ 3000
Histamine H3 Receptor (G Protein Coupled Receptor 97 or GPCR97 or HRH3) - Drugs in Development, 2021

Histamine H3 Receptor (G Protein Coupled Receptor 97 or GPCR97 or HRH3) - Drugs in Development, 2021 Summary Histamine H3 Receptor (G Protein Couple...

Published: Apr-2021 | No. of Pages: 40
$ 3000